Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidetaka Uryu

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Research Square|November 21, 2023
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneityMatthew Schwede, Katharina Jahn, Jack Kuipers, et al.
Leukemia|February 8, 2022
Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinibYuya Sasaki, Hagop M Kantarjian, Nicholas J Short, et al.
Nature Communications|July 5, 2020
Comprehensive structure-function characterization of DNMT3B and DNMT3A reveals distinctive de novo DNA methylation mechanismsLinfeng Gao, Max Emperle, Yiran Guo, et al.
Oncogene|May 7, 2022
Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeuticDongxu Li, Xufen Yu, Jithesh Kottur, et al.
Nature|June 24, 2021
Phase separation drives aberrant chromatin looping and cancer developmentJeong Hyun Ahn, Eric S Davis, Timothy A Daugird, et al.
Cancer Research|October 2, 2020
Epigenetic Control of <i>Cdkn2a.Arf</i> Protects Tumor-Infiltrating Lymphocytes from Metabolic ExhaustionBrian Koss, Bradley D Shields, Erin M Taylor, et al.
Nature Genetics|November 8, 2022
Histone H3 proline 16 hydroxylation regulates mammalian gene expressionXijuan Liu, Jun Wang, Joshua A Boyer, et al.
Elife|June 19, 2024
<i>SOD1</i> is a synthetic-lethal target in <i>PPM1D</i>-mutant leukemia cellsLinda Zhang, Joanne I Hsu, Etienne D Braekeleer, et al.
Blood Cancer Discovery|April 27, 2023
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid MalignanciesCurtis A Lachowiez, Sanam Loghavi, Zhihong Zeng, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Clonal evolution of hematopoietic stem cells after cancer chemotherapyHidetaka Uryu, Koichi Saeki, Hiroshi Haeno, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Research Square|November 21, 2023
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneityMatthew Schwede, Katharina Jahn, Jack Kuipers, et al.
Leukemia|February 8, 2022
Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinibYuya Sasaki, Hagop M Kantarjian, Nicholas J Short, et al.
Nature Communications|July 5, 2020
Comprehensive structure-function characterization of DNMT3B and DNMT3A reveals distinctive de novo DNA methylation mechanismsLinfeng Gao, Max Emperle, Yiran Guo, et al.
Oncogene|May 7, 2022
Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeuticDongxu Li, Xufen Yu, Jithesh Kottur, et al.
Nature|June 24, 2021
Phase separation drives aberrant chromatin looping and cancer developmentJeong Hyun Ahn, Eric S Davis, Timothy A Daugird, et al.
Cancer Research|October 2, 2020
Epigenetic Control of <i>Cdkn2a.Arf</i> Protects Tumor-Infiltrating Lymphocytes from Metabolic ExhaustionBrian Koss, Bradley D Shields, Erin M Taylor, et al.
Nature Genetics|November 8, 2022
Histone H3 proline 16 hydroxylation regulates mammalian gene expressionXijuan Liu, Jun Wang, Joshua A Boyer, et al.
Elife|June 19, 2024
<i>SOD1</i> is a synthetic-lethal target in <i>PPM1D</i>-mutant leukemia cellsLinda Zhang, Joanne I Hsu, Etienne D Braekeleer, et al.
Blood Cancer Discovery|April 27, 2023
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid MalignanciesCurtis A Lachowiez, Sanam Loghavi, Zhihong Zeng, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Clonal evolution of hematopoietic stem cells after cancer chemotherapyHidetaka Uryu, Koichi Saeki, Hiroshi Haeno, et al.
Pageof 3